- Home
- FORM vs CLDX Comparison
FORM vs CLDX Comparison
Compare FORM & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FORM
- CLDX
- Stock Information
- Founded
- FORM 1993
- CLDX 1983
- Country
- FORM United States
- CLDX United States
- Employees
- FORM N/A
- CLDX N/A
- Industry
- FORM Semiconductors
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- FORM Technology
- CLDX Health Care
- Exchange
- FORM Nasdaq
- CLDX Nasdaq
- Market Cap
- FORM 3.0B
- CLDX 2.9B
- IPO Year
- FORM N/A
- CLDX 2008
- Fundamental
- Price
- FORM $37.80
- CLDX $23.55
- Analyst Decision
- FORM Buy
- CLDX Buy
- Analyst Count
- FORM 8
- CLDX 8
- Target Price
- FORM $55.38
- CLDX $64.83
- AVG Volume (30 Days)
- FORM 761.0K
- CLDX 1.1M
- Earning Date
- FORM 10-30-2024
- CLDX 11-06-2024
- Dividend Yield
- FORM N/A
- CLDX N/A
- EPS Growth
- FORM N/A
- CLDX N/A
- EPS
- FORM 1.72
- CLDX N/A
- Revenue
- FORM $742,279,000.00
- CLDX $9,976,000.00
- Revenue This Year
- FORM $17.59
- CLDX N/A
- Revenue Next Year
- FORM $8.39
- CLDX N/A
- P/E Ratio
- FORM $21.94
- CLDX N/A
- Revenue Growth
- FORM 12.31
- CLDX 128.55
- 52 Week Low
- FORM $36.11
- CLDX $23.49
- 52 Week High
- FORM $63.63
- CLDX $53.18
- Technical
- Relative Strength Index (RSI)
- FORM 34.56
- CLDX 29.53
- Support Level
- FORM $40.51
- CLDX $25.56
- Resistance Level
- FORM $43.70
- CLDX $28.15
- Average True Range (ATR)
- FORM 1.76
- CLDX 1.62
- MACD
- FORM -0.19
- CLDX 0.14
- Stochastic Oscillator
- FORM 2.05
- CLDX 1.27
About FORM FormFactor Inc. FormFactor Inc.
FormFactor Inc designs, develops, manufactures, sells, and supports semiconductor probe card products. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.